Topical Collection on Chronic Myeloid Leukemias
In this topical collection (37 articles)
-
Chronic Myeloid Leukemias (V. Oehler, Section Editor)
CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries
Mika Matsuzaki, Alicia Annamalay… Pages 1-7 -
Chronic Myeloid Leukemias (V Oehler, Section Editor)
The Bone Marrow Immune Microenvironment in CML: Treatment Responses, Treatment-Free Remission, and Therapeutic Vulnerabilities
Shaun David Patterson, Mhairi Copland Pages 19-32 -
Chronic Myeloid Leukemias (G Saglio, Section Editor)
Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
Dakota Gustafson, Jason E. Fish… Pages 20-30 -
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia
Ellin Berman Pages 33-39 -
Chronic Myeloid Leukemias (M Mauro, Section Editor)
Treatment-Free Remission in CML: the US Perspective
Guru Subramanian Guru Murthy, Ehab Atallah Pages 56-61 -
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Lauren Caldemeyer, Michael Dugan, John Edwards… Pages 71-79 -
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
The Role of Early Molecular Response in the Management of Chronic Phase CML
Patrick Harrington, Aytug Kizilors… Pages 79-84 -
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia
Kathryn E. Flynn, Ehab Atallah Pages 80-85 -
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase
Sudipto Mukherjee, Matt Kalaycio Pages 86-93 -
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
New Methodologies in the Molecular Monitoring of CML
Cecilia C. S. Yeung, Daniel Egan, Jerald Radich Pages 94-101 -
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Management of Chronic Myeloid Leukemia in Children and Young Adults
Maegan Ford, Michael Mauro, Catherine Aftandilian… Pages 121-126 -
Chronic Myeloid Leukemias (E Jabbour, Section Editor)
Selecting the Best Frontline Treatment in Chronic Myeloid Leukemia
Musa Yilmaz, Yasmin Abaza, Elias Jabbour Pages 145-157 -
Chronic Myeloid Leukemias (E Jabbour, Section Editor)
Chronic Myeloid Leukemia: Advances in Understanding Disease Biology and Mechanisms of Resistance to Tyrosine Kinase Inhibitors
Christopher A. Eide, Thomas O’Hare Pages 158-166 -
Chronic Myeloid Leukemias (E Jabbour, Section Editor)
Milestones and Monitoring
Alessandro Morotti, Carmen Fava, Giuseppe Saglio Pages 167-172 -
ReviewPaper
Real-world Management of CML: Outcomes and Treatment Patterns
Nicole Held, Ehab L. Atallah Pages 167-175 -
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
Nur Hezrin Shahrin, Carol Wadham, Susan Branford Pages 171-180 -
Chronic Myeloid Leukemias (E Jabbour, Section Editor)
Management of Advanced-Phase Chronic Myeloid Leukemia
Zachariah DeFilipp, Hanna Jean Khoury Pages 173-181 -
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Management of Ibrutinib Toxicities: a Practical Guide
Masa Lasica, Constantine S. Tam Pages 177-186
Continue reading...
To view the rest of this content please follow the download PDF link above.